THOMAS VANWOLLEGHEM

Conference Paper
C3
open access

Mitochondrial cardiotoxicity of a prototype HCV NS3-protease inhibitor is characterized by a specific electrocardiographic signature in mice

THOMAS VANWOLLEGHEM (UGent) , Eva Van Braeckel (UGent) , Joél Smet (UGent) , Bi-Sheng Liu, Philip Meuleman (UGent) , Harry L Janssen, Tania Roskams, Rudy Van Coster (UGent) , Rita De Vos and Geert Leroux-Roels (UGent)

(2012) HEPATOLOGY. 56(4, suppl. 1). p.1073A-1074A

Add to list

PhD Thesis

The human liver-uPA-SCID mouse. Optimisation and Application for the in vivo study of anti-Hepatitis C Virus strategies.

THOMAS VANWOLLEGHEM (UGent)

(2011)

Add to list

In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus

Philip Meuleman (UGent) , Jens Bukh, Lieven Verhoye (UGent) , Aliasghar Farhoudi Moghadam (UGent) , THOMAS VANWOLLEGHEM (UGent) , Richard Y Wang, Isabelle Desombere (UGent) , Harvey Alter, Robert H Purcell and Geert Leroux-Roels (UGent)

(2011) HEPATOLOGY. 53(3). p.755-762

Add to list

Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice

THOMAS VANWOLLEGHEM (UGent) , Louis Libbrecht (UGent) , Bettina E Hansen, Isabelle Desombere (UGent) , Tania Roskams, Philip Meuleman (UGent) and Geert Leroux-Roels (UGent)

(2010) JOURNAL OF HEPATOLOGY. 53(3). p.468-476

Add to list

Experimental models for hepatitis C viral infection

Andre Boonstra, Luc van der Laan, THOMAS VANWOLLEGHEM (UGent) and Harry Janssen

(2009) Hepatology. 50(5). p.1646-1655

Add to list

ANTI-CD81 ANTIBODIES CAN PREVENT A HEPATITIS C VIRUS INFECTION IN VIVO

Philip Meuleman (UGent) , Joseph Hesselgesser, Matthew Paulson, THOMAS VANWOLLEGHEM (UGent) , Isabelle Desombere (UGent) , Hans Reiser and Geert Leroux-Roels (UGent)

(2008) Hepatology. 48(4, Suppl. S). p.1016-1016

Add to list

Anti-CD81 Antibodies Can Prevent a Hepatitis C Virus Infection In Vivo

Philip Meuleman (UGent) , Joseph Hesselgesser, Matthew Paulson, THOMAS VANWOLLEGHEM (UGent) , Isabelle Desombere (UGent) , Ilans Reiser and Geert Leroux-Roels (UGent)

(2008) HEPATOLOGY. 48(6). p.1761-1768

Add to list

Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain

THOMAS VANWOLLEGHEM (UGent) , J BUKH, Philip Meuleman (UGent) , Isabelle Desombere (UGent) , JC MEUNIER, H ALTER, RH PURCELL and Geert Leroux-Roels (UGent)

(2008) HEPATOLOGY. 47(6). p.1846-1855

Add to list

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity

J GROVE, T HUBY, Z STAMATAKI, THOMAS VANWOLLEGHEM (UGent) , Philip Meuleman (UGent) , M FARQUHAR, A SCHWARZ, M MOREAU, JS OWEN, Geert Leroux-Roels (UGent) , et al.

(2007) JOURNAL OF VIROLOGY. 81(7). p.3162-3169

Add to list

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial

Isabel Leroux-Roels (UGent) , Astrid Borkowski, THOMAS VANWOLLEGHEM (UGent) , Mamadou Drame, Frédéric Clement (UGent) , Eliane Hons, Jeanne-Marie Devaster and Geert Leroux-Roels (UGent)

(2007) LANCET. 370(9587). p.580-589

Academic Bibliography

THOMAS VANWOLLEGHEM

Mitochondrial cardiotoxicity of a prototype HCV NS3-protease inhibitor is characterized by a specific electrocardiographic signature in mice

The human liver-uPA-SCID mouse. Optimisation and Application for the in vivo study of anti-Hepatitis C Virus strategies.

In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus

Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice

Experimental models for hepatitis C viral infection

ANTI-CD81 ANTIBODIES CAN PREVENT A HEPATITIS C VIRUS INFECTION IN VIVO

Anti-CD81 Antibodies Can Prevent a Hepatitis C Virus Infection In Vivo

Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial

Contents

Support

Contact